RecruitingNCT06636747

High Resolution Diffusion Weighted Imaging in Prostate

A Comparative Study of High Resolution DWI and Conventional DWI in Prostate


Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment

500 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI


Eligibility

Sex: MALEMin Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study compares two types of MRI imaging techniques — standard and high-resolution diffusion-weighted imaging — in men being evaluated for prostate cancer. Researchers want to see if the newer high-resolution technique provides better diagnostic information. **You may be eligible if...** - You are a man who has already undergone a standard prostate MRI that included both techniques - Your medical records are available and complete **You may NOT be eligible if...** - You are currently taking or recently took 5-alpha-reductase inhibitors (a class of prostate medication like finasteride or dutasteride) in the past 6 months - You have had a previous prostate biopsy, prostate surgery, or treatment for prostate cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China

Yu-Dong Zhang

Nanjing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06636747


Related Trials